Iclusig (ponatinib) is an oral drug developed by ARIAD Pharmaceuticals for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is a multi-targeted tyrosine kinase inhibitor. Ponatinib is used to treat certain types of blood cancer (chronic myelogenous leukemia-CML, acute lymphoblastic leukemia-ALL). It works by slowing or stopping the growth of […]